New Insights in the Molecular Mechanism of Progestin-induced Proliferation of Mammary Epithelium: Induction of the Local Biosynthesis of Growth Hormone (GH) in the Mammary Gland of Dogs, Cats and Humans

Journal of Steroid Biochemistry and Molecular Biology

Volumn 57, Issue 1-2, 1996, Pages 67-71

  Mol, J A ^a   Van Garderen, E ^a   Rutteman, G R ^a   Rijnberk, A ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; MEDROXYPROGESTERONE ACETATE; MIFEPRISTONE; PROLIGESTONE; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ARTICLE; BREAST EPITHELIUM; CAT; CELL PROLIFERATION; CONTROLLED STUDY; DOG; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL;

ANIMALS; BREAST; CATS; CELL DIVISION; DOGS; EPITHELIAL CELLS; EPITHELIUM; FEMALE; GENE EXPRESSION REGULATION; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; MENSTRUAL CYCLE; MODELS, BIOLOGICAL; PROGESTINS; RNA, MESSENGER;

CANIS FAMILIARIS; FELIS CATUS;

EID: 0029876940     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-0760(95)00251-0     Document Type: Article

References (44)

1. Gräf K. J. and El Etreby M. F.: Endocrinology of reproduction in the female beagle dog and its significance in mammary gland tumorigenesis. Acta Endocr. (Copenh.) 222(suppl) (1979) 1-33.
2. Rijnberk A., Eigenmann J. E., Belshaw B. E., Hampshire J. and Altszuler N.: Acromegaly associated with transient overproduction of growth hormone in a dog. J. Am. Vet. Med. Assoc. 177 (1980) 534-537.
3. Concannon P., Altszuler N., Hampshire J., Butler R. W. and Hansel W.: Growth hormone, prolactin, and cortisol in dogs developing mammary nodules and an acromegaly-like appearance during treatment with medroxyprogesterone acetate. Endocrinology 106 (1980) 1173-1177.
4. Eigenmann J. E., Eigenmann R. Y., Rijnberk A., van der Gaag I., Zapf J. and Froesch E. R.: Progestagen-controlled growth hormone overproduction and naturally occurring canine diabetes and acromegaly. Acta Endocr. (Copenh.) 104 (1983) 167-176.
5. Horwitz K. B.: The molecular biology of RU 486. Is there a role for antiprogestins in the treatment of breast cancer? Endocrine Rev. 13 (1991) 146-162.
6. Clarke C. L. and Sutherland R. L.: Progestin regulation of cellular proliferation. Endocrine Rev. 11 (1990) 266-301.
7. Van Leeuwen F. E.: Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer. Acta Endocr. (Copenh.) 125 (Suppl. 1) (1991) 13-26.
8. King R. J. B.: Biology of female sex hormone action in relation to contraceptive agents and neoplasia. Contraception 43 (1991) 527-542.
9. Bakker G. H., Setyono-Han B., Portengen H., De Jong F. H., Foekens J. A. and Klijn J. G.: Endocrine and antitumor effects of combined treatment with an antiprogestin and antiestrogen or luteinizing hormone-releasing hormone agonist in female rats bearing mammary tumors. Endocrinology 125 (1989) 1593-1598.
10. Rutteman G. R.: Contraceptive steroids and the mammary gland: is there a hazard? Breast Cancer Res. Treat. 23 (1992) 29-41.
11. Braunsberg H., Coldham N. G., Leake R. E., Cowan S. K. and Wong W.: Actions of a progestogen on human breast cancer cells: mechanisms of growth stimulation and inhibition. Eur. J. Cancer Clin. Oncol. 23 (1987) 563-571.
12. Sutherland R. L., Hall R. E., Pang G. Y. N., Musgrove E. A. and Clarke C. L.: Effect of medroxyprogesterone acetate on proliferation and cell cycle kinetics of human mammary carcinoma cells. Cancer Res. 48 (1988) 5084-5091.
13. Musgrove E. A. and Sutherland R. L.: Effects of the progestin antagonist RU486 on T-47D breast cancer cell cycle kinetics and cell cycle regulatory genes. Biochem. Biophys. Res. Commun. 195 (1993) 1184-1190.
14. Kalkhoven E., Kwakkenbos-Isbrucker L., De Laat S. W., Van der Saag P. T. and Van der Burg B.: Synthetic progestins induce proliferation of breast tumor cell lines via the progesterone or estrogen receptor. Molec. Cell. Endocr. 102 (1994) 45-52.
15. Papa V., Reese C. C., Brunetti A., Vigneri R., Siiteri P. K. and Goldfine I. D.: Progestins increase insulin receptor content and insulin stimulation of growth in human breast carcinoma cells. Cancer Res. 50 (1990) 7858-7862.
16. Alexander I. E., Clarke C. L., Shine J. and Sutherland R. L.: Progestin inhibition of progesterone receptor gene expression in human breast cancer cells. Molec. Endocrin. 3 (1989) 1377-1386.
17. Diamond M. I., Miner J. N., Yoshinaga S. K. and Yamamoto K. R.: Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science 249 (1990) 1266-1272.
18. Slootweg M. C., de Groot R. P., Herrmann-Erlee M. P., Koornneef I., Kruijer W. and Kramer Y. M.: Growth hormone induces expression of c-jun and jun B oncogenes and employs a protein kinase C signal transduction pathway for the induction of c-fos oncogene expression. J. Molec. Endocr. 6 (1991) 179-188.
19. Van der Burg B., Van Selm-Miltenburg A. J. P., De Laat S. W. and Van Zoelen E. J. J.: Direct effects of estrogen on c-fos and c-myc protooncogene expression and cellular proliferation in human breast cancer cells. Molec. Cell. Endocr. 64 (1989) 223-228.
20. Beck C. A., Weigel N. L., Moyer M. L., Nordeen S. K. and Edwards D. P.: The progesterone antagonist RU486 acquires agonist activity upon stimulation of cAMP signaling pathways. Proc. Natn. Acad. Sci. U.S.A. 90 (1993) 4441-4445.
21. Sartorius C. A., Tung L., Takimoto G. S. and Horwitz K. B.: Antagonist-occupied human progesterone receptors bound to DNA are functionally switched to transcriptional agonists by cAMP. J. Biol. Chem. 268 (1993) 9262-9266.
22. French M. B., Vaitkus P., Cukerman E., Sirek A. and Sirek O. V.: Secretory pattern of canine growth hormone. Am. J. Physiol. 252 (1987) E268-E272.
23. Watson A. D. J., Rutteman G. R., Rijnberk A. and Mol J. A.: Effect of somatostatin analogue SMS 201-995 and antiprogestin agent RU486 in canine acromegaly. Front. Horm Res. 17 (1987) 193-198.
24. Muruais J., Penalva A., Dieguez C. and Casanueva F. F.: Influence of endogenous cholinergic tone and alpha-adrenergic pathways on growth hormone responses to His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 in the dog. J. Endrocr. 138 (1993) 211-218.
25. Cheng K., Chan W. W., Butler B., Barreto A. Jr and Smith R. G.: Evidence for a role of protein kincase-C in His-D-Trp-Ala-Trp-D-Phe-Lys-NH2-induced growth hormone release from rat primary pituitary cells. Endocrinology 129 (1991) 3337-3342.
26. Frohman L. A., Downs T. R. and Sato M.: Neuroendocrine control of growth hormone (GH) secretion: studies in transgenic and genetic strains of mice and rats. J. Endocr. Invest. 15 (suppl. 4) (1992) 15.
27. Lamberts S. W. J. and Oosterom R.: The regulation of growth hormone secretion. Front. Horm. Res. 14 (1985) 137-160.
28. Hall T. R., Harvey S. and Scanes C. G.: Control of growth hormone secretion in the vertebrates: a comparative study. Comp. Biochem. Physiol. 2 (1986) 231-253.
29. Lin C. J., Lin S. C., Chang C. P. and Rosenfeld M. G.: Pit-1-dependent expression of the receptor for growth hormone releasing factor mediates pituitary cell growth. Nature 360 (1992) 765-768.
30. Sittler A. M. and Reudelhuber T. L.: Tissue-specific expression of the rat growth hormone gene is due to the interaction of multiple promotor, not enhancer, elements. DNA Cell Biol. 9 (1990) 511-518.
31. Selman P. J., Mol J. A., Rutteman G. R. and Rijnberk A.: Progestin treatment in the dog: I. Effects on growth hormone, IGF-I, and glucose homeostasis. Eur. J. Endocr. 131 (1994) 413-421.
32. Selman P. J., Mol J. A., Rutteman G. R. and Rijnberk A.: Progestins and growth hormone excess in the dog. Acta Endocr. (Copenh.) 125 (Suppl. 1) (1991) 42-47.
33. Selman P. J., Mol J. A., van Garderen E., Rutteman G. R. and Rijnberk A.: Progestin-induced growth hormone excess originates in the mammary gland. Endocrinology 134 (1994) 287-292.
34. Mol J. A., van Garderen E., Selman P. J., Wolfswinkel J., Rijnberk A. and Rutteman G. R.: Growth hormone mRNA in mammary gland tumors of dogs and cats. J. Clin. Invest. 95 (1995) 2028-2034.
35. Mol J. A., Hageman P., Misdorp W., Blankestein M. R., Henze S. and Rijnberk A.: Expression of the gene encoding pituitary growth hormone in human mammary gland tumors. J. Clin. Endocr. Metab. 80 (1995) 3094-3096.
36. Frankenne F., Rentier Delrue F., Scippo M. L., Martial J. and Hennen G.: Expression of the growth hormone variant gene in human placenta. J. Clin. Endocr. Metab. 64 (1987) 635-637.
37. Faria A. C., Bekenstein L. W., Booth R. A. Jr, Vaccaro V. A., Asplin C. M., Veldhuis J. D., Thorner M. O. and Evans W. S.: Pulsatile growth hormone release in normal women during the menstrual cycle. Clin. Endocr. (Oxf.) 36 (1992) 591-596.
38. Russo I. H. and Russo J.: Progestagens and mammary gland development: differentiation versus carcinogenesis. Acta Endocr. (Copenh.) 125 (Suppl. 1) (1991) 7-12.
39. Andres A. C., Bchini O., Schubaur B., Dolder B., LeMeur M. and Gerlinger P.: H-ras induced transformation of mammary epithelium is favoured by increased oncogene expression or by inhibition of mammary regression. Oncogene 6 (1991) 771-779.
40. Bonneterre J., Peyrat J. P., Beuscart R. and Demaille A.: Biological and clinical aspects of prolactin receptors (PRL-R) in human breast cancer. J. Steroid Biochem. Molec. Biol. 37 (1990) 977-981.
41. Cullen K. J., Allison A., Martire I., Ellis M. and Singer C.: Insulin-like growth factor expression in breast cancer epithelium and stroma. Breast Cancer Res. Treat. 22 (1992) 21-29.
42. Van der Burg B.: Growth factor secretion by autonomously growing canine mammary cancer cell lines. In Molecular Action of Steroids and Growth Factors in Breast Tumor Cells. Thesis, Utrecht University (1990).
43. Hellmen E. and Lindgren A.: The expression of intermediate filaments in canine mammary glands and their tumors. Vet. Path. 26 (1989) 420-428.
44. Ruan W., Newman C. B. and Kleinberg D. L.: Intact and amino-terminally shortened forms of insulin-like growth factor I induce mammary gland differentiation and development. Proc. Natn. Acad. Sci. U.S.A. 89 (1992) 10,872-10,876.